Cellectis Balance Sheet Health
Financial Health criteria checks 5/6
Cellectis has a total shareholder equity of $148.6M and total debt of $43.0M, which brings its debt-to-equity ratio to 28.9%. Its total assets and total liabilities are $407.1M and $258.5M respectively.
Key information
28.9%
Debt to equity ratio
US$42.98m
Debt
| Interest coverage ratio | n/a |
| Cash | US$149.04m |
| Equity | US$148.61m |
| Total liabilities | US$258.54m |
| Total assets | US$407.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CMVL.F's short term assets ($305.8M) exceed its short term liabilities ($159.6M).
Long Term Liabilities: CMVL.F's short term assets ($305.8M) exceed its long term liabilities ($98.9M).
Debt to Equity History and Analysis
Debt Level: CMVL.F has more cash than its total debt.
Reducing Debt: CMVL.F's debt to equity ratio has increased from 0% to 28.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CMVL.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CMVL.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 6.9% per year.